Accueil>>Signaling Pathways>> Others>> Inhibitory Antibodies>>Inclacumab

Inclacumab (Synonyms: Anti-Human selectin P Recombinant Antibody)

Catalog No.GC69275

Inclacumab (anticorps recombinant anti-sélectine P humaine) est un anticorps monoclonal IgG4 humanisé ciblant sélectivement la P-sélectine, avec une valeur de Kd de 9,9 nM. Inclacumab inhibe la liaison du peptide simulateur PSGL-1 (protéine adhésive des leucocytes associée au système glycoprotéique) à la P-sélectine, avec une valeur d'IC50 de 1,9 µg/mL. Inclacumab inhibe fortement l'adhésion cellulaire.

Products are for research use only. Not for human use. We do not sell to patients.

Inclacumab Chemical Structure

Cas No.: 1256258-86-2

Taille Prix Stock Qté
5mg
819,00 $US
En stock
10mg
1 310,40 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Inclacumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Inclacumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.